Company Mission

The current trend in the clinical studies industry is toward increasing complexity in activities and procedures. Meanwhile, the costs and resource demands for contract research organizations (CROs) are rising. This trend results in higher prices for clinical trials and longer timelines from concept to final report. Consequently, pharmaceutical companies are finding it increasingly difficult to expand their research and development budgets. As a result, there has been a recent decline in innovative developments. Small pharmaceutical companies, faced with these conditions, are increasingly abandoning the idea of launching both interventional studies and post-marketing projects.

In response to these trends, the company has defined its mission: to increase the availability of clinical study services and to accelerate the market entry of effective new drugs and medical devices.

We view this mission as the goal we are committed to achieving. To reach this goal, we implement an approach consisting of three key components:

• The company’s main asset is its employees. We create conditions that allow Pharmaxi’s employees to fully realize their potential.
• Innovation and process automation. Increasing productivity relies on integrating advanced information technologies into clinical research processes. Many of our processes are centered around our specially developed electronic system, OnlineCRF. Additionally, we use tools such as cloud services, task managers, issue trackers, CRM systems, and others to organize our work.
• Efficiency as a guiding principle. While complete efficiency may never be fully achieved, there is always room for simplification and modernization. This applies to both employee productivity and company procedures. We are guided by the Japanese ideology of continuous self-improvement.